SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000880771-16-000150
Filing Date
2016-08-03
Accepted
2016-08-03 14:00:44
Documents
3
Period of Report
2016-08-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scln-20160803x8k.htm 8-K 25963
2 EX-99.1 scln-20160803xex99_1.htm EX-99.1 43428
3 GRAPHIC scln-20160803xex99_1g001.jpg GRAPHIC 9400
  Complete submission text file 0000880771-16-000150.txt   83751
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 161803321
SIC: 2834 Pharmaceutical Preparations